It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Progressive rod-cone degeneration (PRCD) is a small protein localized to photoreceptor outer segment (OS) disc membranes. Several mutations in PRCD are linked to retinitis pigmentosa (RP) in canines and humans, and while recent studies have established that PRCD is required for high fidelity disc morphogenesis, its precise role in this process remains a mystery. To better understand the part which PRCD plays in disease progression as well as its contribution to photoreceptor OS disc morphogenesis, we generated a Prcd-KO animal model using CRISPR/Cas9. Loss of PRCD from the retina results in reduced visual function accompanied by slow rod photoreceptor degeneration. We observed a significant decrease in rhodopsin levels in Prcd-KO retina prior to photoreceptor degeneration. Furthermore, ultrastructural analysis demonstrates that rod photoreceptors lacking PRCD display disoriented and dysmorphic OS disc membranes. Strikingly, atomic force microscopy reveals that many disc membranes in Prcd-KO rod photoreceptor neurons are irregular, containing fewer rhodopsin molecules and decreased rhodopsin packing density compared to wild-type discs. This study strongly suggests an important role for PRCD in regulation of rhodopsin incorporation and packaging density into disc membranes, a process which, when dysregulated, likely gives rise to the visual defects observed in patients with PRCD-associated RP.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 West Virginia University, Department of Pharmaceutical Sciences, One Medical Center Drive, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, Department of Ophthalmology and Visual Sciences, Eye Institute, One Medical Center Drive, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)
2 West Virginia University, Department of Ophthalmology and Visual Sciences, Eye Institute, One Medical Center Drive, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140); West Virginia University, Department of Biochemistry, One Medical Center Drive, Morgantown, USA (GRID:grid.268154.c) (ISNI:0000 0001 2156 6140)
3 Case Western Reserve University, Department of Ophthalmology and Visual Sciences, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
4 Oakland University, Eye Research Institute, Rochester, USA (GRID:grid.261277.7) (ISNI:0000 0001 2219 916X)